ACADIA Pharmaceuticals Inc. (ACAD): Pimavanserin: The Most Underestimated ... - Seeking Alpha

14-10-2013 Seeking AlphaComments (0)

ACADIA PharmaceuticalsBiotechnology

Acadia Pharmaceuticals (ACAD) has been one of biotechnology's greatest surprises of the year, posting 12-month gains of 800%. Its anti-psychotic drug pimavanserin (pima) showed excellent efficacy without significant side effects in patients with ...

Read more on Seeking Alpha

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top